key: cord-0029564-84870n6c authors: Aledavood, Seyed Amir; Akbari Oryani, Mahsa; Pishevar Feizabad, Zohreh title: Tongue metastasis originated from esophageal squamous cell carcinoma: A case report date: 2022-04-05 journal: Clin Case Rep DOI: 10.1002/ccr3.5648 sha: a966f84ebe78a19e71d90d6ecd31a69fadfd117f doc_id: 29564 cord_uid: 84870n6c The tongue is a rare site for metastasis. In this report, we present a woman with a history of esophageal squamous cell carcinoma who suffered from two metastatic masses on the left side of her tongue 2 years after completion of definitive chemoradiation. The patient underwent chemotherapy and left hemi‐glossectomy. The esophageal squamous cell carcinoma is known as locally recurrent disease which tends less to metastasize to distant organs compared with its counterpart, that is, adenocarcinoma. 1 However, distant metastases might happen, mostly involving liver, lung, and bone, compromising the survival of patients, significantly. 2 The tongue is a rare site for distant metastasis and only few cases from different origins such as gastrointestinal tract or pulmonary system have been reported. [3] [4] [5] Although it is more frequent in patients with disseminated diseases, it could be observed as single site of metastasis or even as the initial presentation of distant metastasis, as well. 5, 6 In this report, we present a woman with a previous history of esophageal squamous cell carcinoma (ESCC) with final diagnosis of the metastasis to tongue 2 years after definitive chemoradiation. A 54-year-old woman with a past history of esophageal squamous cell carcinoma was admitted due to two soft tissue masses on the left side of her tongue. The patient did not mention history of smoking, addiction, or using nasvay. She had no significant past medical history other than her esophageal cancer which was treated by definitive radiation therapy [50 gray/25 fractions during 5 weeks] with concurrent chemotherapy [two cycles of cisplatin (30 mg) and 5-FU (500 mg) day1-3 every 3 weeks]. After treatment, she was followed up every 4 months and had no specific signs and symptoms till 24 months later when she complained of persistent lumps on the left side of her tongue which were present since last 4 months. Physical examination showed there were two separated painless firm masses on the left side of the tongue without any signs of epithelial and mucosal involvement or ulcer. The incisional biopsy showed nondysplastic epithelium lied over a submucosal carcinomatous neoplasm composed of tumoral cell islands with severe atypia and conspicuous nucleoli along with frequent mitosis, necrosis, and lymphovascular invasion ( Figure 1A ,B). The primary pathologic diagnosis was poorly differentiated carcinoma which subsequent immunohistochemistry evaluation showed positive staining for CK and P63 and negative staining for CK5/6, EMA, and CEA leading to final diagnosis of metastatic high-grade squamous cell carcinoma. Esophagogastroduodenoscopy and full-body computerized tomography (CT) scans with and without intravenous contrast were done. Barium meal revealed smooth narrowing of middle esophagus. However, the endoscopic biopsy of esophageal stricture was normal. Cisplatin (cisplatin, 80 mg/m 2 /day, day 1) plus 5-FU (800 mg/m 2 /day, days 1-5) chemotherapy regimen was commenced and repeated every 3 weeks. After four cycles of treatment, the lingual lesions have shrunk, significantly, depicted on the physical examination. Subsequently, the patient underwent left hemi-glossectomy, and pathologic examination revealed pseudoepitheliomatous hyperplasia confirming a pathologic complete response ( Figure 1C,D) . After 1 year of follow-up, she was disease free. The tongue is an unexpected site of distant metastasis for malignant diseases including esophageal cancers and only few reports are available, mostly originated from the esophageal adenocarcinoma. 5, 7 Therefore, the diagnosis of tongue metastasis as a single site of distant metastasis which is originated from esophageal squamous cell carcinoma is a challenging scenario because F I G U R E 1 A (×10) -B (×10): nondysplastic epithelium (*) lied over a submucosal carcinomatous neoplasm composed of tumoral cell islands with severe atypia (___) and conspicuous nucleoli along with frequent mitosis, necrosis, and lymphovascular invasion. C (×40) -D (×10): Total glossectomy following chemotherapy; achieving pathologic complete response following chemotherapy. E (×40): membranous immunostaining of CK20 was seen in tumoral cells F (×40): A strong nuclear p63 immunostaining was seen in tumoral cells of its rarity as the location of metastasis and also possible second primary malignancies of the aerodigestive tract due to potential shared predisposing factors and field cancerization. 8 Histopathologic evaluation might be helpful to distinguish between the primary squamous cell carcinoma of tongue and the metastatic lesions originated from squamous cell carcinoma of other organs. Intact nondysplastic epithelium of tongue is the main characteristic of metastatic lesions as reported in the current case. Patients with metastatic esophageal squamous cell carcinoma usually suffer from disseminated disease and single distant metastasis, especially to the tongue, is extremely uncommon. Despite the positron emission tomography-computed tomography (PET-CT) scan was not performed in our patient, results of the extensive investigations including esophagogastroduodenoscopy and full-body CT scan did not show neither local nor distant recurrent except the lingual lesion. Because of the rarity of condition, no standard approach for the treatment of patients has been proposed. Considering the morbidity of surgical resection in patients with malignancy of tongue, palliative chemotherapy and or radiotherapy, if there is no overlap with previous radiation plans, are among the best treatment options. 10, 11 The presented patient with solitary distant metastases from esophageal cancer underwent definitive surgery after the preliminary chemotherapy showing a complete response at the pathologic examinations. Definitive surgery can be offered to patients with the isolated recurrence from esophageal cancer without any other evidence of local or distant metastasis and offer a survival benefit for properly selected patients. 12 Beside the conventional chemotherapeutic agent, 13 innovation of newer treatment approaches such as targeted therapy and immunotherapy, [14] [15] [16] [17] introducing newer techniques in delivering the radiotherapy, 18, 19 and finding newer markers to assess the response to treatments 20,21 may improve the survival of patients with metastatic esophageal cancer including people with distant metastasis to rare sites. The tongue is a rare site for distant metastasis. However, in patients with a history of malignancy, any persistent lingual mass should be assessed carefully, regardless of its appearance, growth rate, ulceration, and neural symptoms. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma Patterns of distant organ metastases in esophageal cancer: a population-based study A case report of tongue metastasis from lung squamous cell carcinoma and literature review Colorectal adenocarcinoma metastasis to the tongue Tongue metastasis as an initial manifestation of distant metastasis in Oesophageal Adenocarcinoma Metastatic tumor to the tongue: report of twelve cases. Oral Surg Oral Med Oral Pathol Esophageal cancer metastases to unexpected sites: a systematic review Squamous cell carcinoma of the upper Aerodigestive tract: precursors and problematic variants A case of esophageal cancer metastasizing to the tongue Radical radiotherapy for metachronous oligometastasis after initial treatment of esophageal cancer Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases The role of surgical treatment in isolated organ recurrence of esophageal cancer-a systematic review of the literature 5-fluorouracil: a narrative review on the role of regulatory mechanisms in driving resistance to this chemotherapeutic agent Anti-tumoral effects of low molecular weight heparins: a focus on the treatment of esophageal cancer A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer Advances in targeted therapy for esophageal cancer The esophageal cancer and the PI3K/AKT/mTOR signaling regulatory mi-croRNAs: a novel marker for prognosis, and a possible target for immunotherapy Clinical efficacy and side effects of IORT as tumor bed boost during breast-conserving surgery in breast cancer patients following neoadjuvant chemotherapy Feasibility of treatment planning system in localizing the COVID-19 Pneumonia lesions and evaluation of volume indices of lung involvement Changes in cytokeratin 18 during neoadjuvant chemotherapy of breast cancer: a prospective study Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: a novel biomarker for prognosis, and a possible target for immunotherapy We would like to thank the patient for her consent for publication of the data. The authors declare that they have no conflicts of interest. The author listed is the sole author. S.A.A. supervised the case report and contributed to the final version of the manuscript. Z.P.F. contributed to the interpretation of the results and took the lead in writing the manuscript. M.A.O. provided the pathologic images and contributed to the interpretation of them. All authors discussed the results and commented on the manuscript. An informed written consent form was obtained from the patient. An informed written consent form was obtained from the patient. The data that support the findings of this study are available from the corresponding author upon reasonable request. Zohreh Pishevar Feizabad https://orcid. org/0000-0001-9527-6226